Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia

NCT02968121 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
22
Enrollment
INDUSTRY
Sponsor class

Stopped Part A of study was completed per protocol. Conduct of Part B of the study (confirmatory phase) was not necessary.

Conditions

Interventions

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators